Orphan designation: iniparib Treatment of glioma, 12/09/2025 Positive
Submitted by Anonymous (not verified) on 26 March 2026 - 12:51
Orphan designation: iniparib Treatment of glioma, 12/09/2025 Positive
Orphan designation: potravitug Treatment in solid organ transplantation, 15/12/2025 Positive
Submitted by Anonymous (not verified) on 26 March 2026 - 12:45
Orphan designation: potravitug Treatment in solid organ transplantation, 15/12/2025 Positive
Vaccine-preventable diseases: key facts
Submitted by Anonymous (not verified) on 26 March 2026 - 12:26
Vaccine-preventable diseases: key facts
Vaccine Essentials: Supporting vaccine literacy
Submitted by Anonymous (not verified) on 26 March 2026 - 12:23
Vaccine Essentials: Supporting vaccine literacy
Vaccine Essentials: Meningococcal group B vaccines - facts and figures overview
Submitted by Anonymous (not verified) on 26 March 2026 - 12:22
Vaccine Essentials: Meningococcal group B vaccines - facts and figures overview
Pharmaceutical quality system (PQS) effectiveness pilot project
Submitted by Anonymous (not verified) on 26 March 2026 - 9:40
Pharmaceutical quality system (PQS) effectiveness pilot project
Clinical Trials Information System (CTIS): training and support
Submitted by Anonymous (not verified) on 26 March 2026 - 8:15
Clinical Trials Information System (CTIS): training and support
Clinical Trial Information System (CTIS) - Sponsor Frequently Asked Questions (FAQ)
Submitted by Anonymous (not verified) on 26 March 2026 - 8:14
Clinical Trial Information System (CTIS) - Sponsor Frequently Asked Questions (FAQ)
Clinical Trial Information System (CTIS) - Sponsor handbook
Submitted by Anonymous (not verified) on 26 March 2026 - 8:13
Clinical Trial Information System (CTIS) - Sponsor handbook
Orphan designation: deupirfenidone Treatment idiopathic pulmonary fibrosis, 09/01/2026 Positive
Submitted by Anonymous (not verified) on 25 March 2026 - 16:59
Orphan designation: deupirfenidone Treatment idiopathic pulmonary fibrosis, 09/01/2026 Positive